Owens & Minor (NYSE:OMI) Given New $18.50 Price Target at Citigroup

Owens & Minor (NYSE:OMI) had its price objective cut by Citigroup from $21.00 to $18.50 in a report published on Tuesday, Benzinga reports. They currently have a buy rating on the stock.

Other equities analysts also recently issued research reports about the company. Robert W. Baird cut their price objective on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research report on Tuesday. JPMorgan Chase & Co. cut their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a report on Wednesday, August 21st. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a research report on Monday, August 26th. Finally, Barclays reduced their target price on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $18.50.

Owens & Minor Stock Down 1.8 %

OMI opened at $11.78 on Tuesday. The firm has a market cap of $908.24 million, a price-to-earnings ratio of -21.04, a PEG ratio of 0.43 and a beta of 0.41. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.51 and a current ratio of 1.09. The firm’s 50-day simple moving average is $14.54 and its 200-day simple moving average is $16.19. Owens & Minor has a twelve month low of $11.42 and a twelve month high of $28.35.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. The firm had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.68 billion. During the same period in the prior year, the firm earned $0.44 earnings per share. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. Equities research analysts anticipate that Owens & Minor will post 1.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Owens & Minor

Several institutional investors have recently modified their holdings of the business. Allspring Global Investments Holdings LLC lifted its holdings in Owens & Minor by 43,142.9% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,027 shares of the company’s stock valued at $84,000 after buying an additional 3,020 shares during the period. BNP Paribas Financial Markets raised its position in shares of Owens & Minor by 118.2% during the 1st quarter. BNP Paribas Financial Markets now owns 47,587 shares of the company’s stock valued at $1,319,000 after acquiring an additional 25,779 shares during the last quarter. Janney Montgomery Scott LLC bought a new stake in shares of Owens & Minor during the 1st quarter valued at $358,000. Texas Permanent School Fund Corp lifted its stake in shares of Owens & Minor by 1.8% in the 1st quarter. Texas Permanent School Fund Corp now owns 66,953 shares of the company’s stock valued at $1,855,000 after purchasing an additional 1,156 shares during the period. Finally, Empowered Funds LLC boosted its position in shares of Owens & Minor by 8.2% in the 1st quarter. Empowered Funds LLC now owns 297,574 shares of the company’s stock worth $8,246,000 after purchasing an additional 22,509 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.